Published in Ann Neurol on June 27, 2014
A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol (2016) 2.86
Status epilepticus of inflammatory etiology: a cohort study. Neurology (2015) 2.02
Autoimmune post-herpes simplex encephalitis of adults and teenagers. Neurology (2015) 1.83
Autoimmune encephalopathies. Ann N Y Acad Sci (2014) 1.65
Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice. Brain (2014) 1.59
Anti-NMDA Receptor Encephalitis in the Polar Bear (Ursus maritimus) Knut. Sci Rep (2015) 1.00
Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response. JAMA Neurol (2015) 1.00
Anti-NMDA receptor encephalitis, autoimmunity, and psychosis. Schizophr Res (2014) 0.96
Neuroinflammation: Ways in Which the Immune System Affects the Brain. Neurotherapeutics (2015) 0.93
Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome. J Neuroinflammation (2016) 0.91
Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases. Front Immunol (2015) 0.83
Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications. Psychopharmacology (Berl) (2015) 0.82
Limbic Encephalitis: Potential Impact of Adaptive Autoimmune Inflammation on Neuronal Circuits of the Amygdala. Front Neurol (2015) 0.82
Earlier treatment of NMDAR antibody encephalitis in children results in a better outcome. Neurol Neuroimmunol Neuroinflamm (2015) 0.82
Neuronal surface antibody-mediated autoimmune encephalitis. Semin Neurol (2014) 0.82
Association of Progressive Cerebellar Atrophy With Long-term Outcome in Patients With Anti-N-Methyl-d-Aspartate Receptor Encephalitis. JAMA Neurol (2016) 0.81
Detection and Characterization of Autoantibodies to Neuronal Cell-Surface Antigens in the Central Nervous System. Front Mol Neurosci (2016) 0.81
Plasticity-related gene 5: A novel surface autoantigen in paraneoplastic cerebellar degeneration. Neurol Neuroimmunol Neuroinflamm (2015) 0.80
CD8(+) T Cell-Mediated Neuronal Dysfunction and Degeneration in Limbic Encephalitis. Front Neurol (2015) 0.78
Progress in autoimmune epileptic encephalitis. Curr Opin Neurol (2016) 0.78
Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System. Physiol Rev (2017) 0.78
Red Flags: Clinical Signs for Identifying Autoimmune Encephalitis in Psychiatric Patients. Front Psychiatry (2017) 0.77
Serum from a Patient with GAD65 Antibody-Associated Limbic Encephalitis Did Not Alter GABAergic Neurotransmission in Cultured Hippocampal Networks. Front Neurol (2015) 0.77
Characterising seizures in anti-NMDA-receptor encephalitis with dynamic causal modelling. Neuroimage (2015) 0.77
Seizures and Epilepsies due to Channelopathies and Neurotransmitter Receptor Dysfunction: A Parallel between Genetic and Immune Aspects. Mol Syndromol (2016) 0.76
Mechanisms of Autoantibody-Induced Pathology. Front Immunol (2017) 0.76
NMDA receptor encephalitis and other antibody-mediated disorders of the synapse: The 2016 Cotzias Lecture. Neurology (2016) 0.76
Targeting brain cells with glutathione-modulated nanoliposomes: in vitro and in vivo study. Drug Des Devel Ther (2015) 0.76
Paving the Way to Understand Autoantibody-Mediated Epilepsy on the Molecular Level. Front Neurol (2015) 0.76
Follow Thy Bear: The NMDA Receptor Antibodies Are Epileptogenic. Epilepsy Curr (2016) 0.75
In vitro effects of a human monoclonal antibody against the N-methyl-d-aspartate receptor. Brain (2016) 0.75
Neuronal central nervous system syndromes probably mediated by autoantibodies. Eur J Neurosci (2016) 0.75
DPPX antibody-associated encephalitis: Main syndrome and antibody effects. Neurology (2017) 0.75
A mouse model of autoimmune encephalitis. Brain (2015) 0.75
Adaptive Immunity Is the Key to the Understanding of Autoimmune and Paraneoplastic Inflammatory Central Nervous System Disorders. Front Immunol (2017) 0.75
Anti-N-Methyl-D-aspartate Receptor Encephalitis: A Severe, Potentially Reversible Autoimmune Encephalitis. Mediators Inflamm (2017) 0.75
Editorial: Induction of Central Nervous System Disease by the Adaptive Immune Response. Front Immunol (2017) 0.75
Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia. NPJ Schizophr (2017) 0.75
Advances in Autoimmune Epilepsy Associated with Antibodies, Their Potential Pathogenic Molecular Mechanisms, and Current Recommended Immunotherapies. Front Immunol (2017) 0.75
N-methyl-D-aspartate receptor encephalitis mediates loss of intrinsic activity measured by functional MRI. J Neurol (2016) 0.75
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol (2008) 21.53
Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol (2007) 16.81
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol (2013) 11.47
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry (1994) 8.88
The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell (1996) 6.96
Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci (2010) 6.44
NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci (2007) 6.26
Synaptic AMPA receptor plasticity and behavior. Neuron (2009) 5.58
Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci (1997) 5.30
Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci (2008) 5.12
Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell (1999) 4.93
NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res (2000) 4.66
Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol (2006) 4.60
How inhibition shapes cortical activity. Neuron (2011) 4.53
AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol (2009) 4.49
NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci (2007) 4.35
Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat Neurosci (2009) 4.32
Molecular determinants of NMDA receptor internalization. Nat Neurosci (2001) 2.79
Rapid synaptic scaling induced by changes in postsynaptic firing. Neuron (2008) 2.70
Activity regulates the synaptic localization of the NMDA receptor in hippocampal neurons. Neuron (1997) 2.59
Homeostatic signaling: the positive side of negative feedback. Curr Opin Neurobiol (2007) 2.58
Activity coregulates quantal AMPA and NMDA currents at neocortical synapses. Neuron (2000) 2.43
Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis. Brain (2012) 2.39
NMDA-dependent modulation of CA1 local circuit inhibition. J Neurosci (1996) 2.35
Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis. Neurology (2011) 2.32
Inducible and reversible NR1 knockout reveals crucial role of the NMDA receptor in preserving remote memories in the brain. Neuron (2004) 2.31
Glycine binding primes NMDA receptor internalization. Nature (2003) 2.30
Neuronal activity-regulated gene transcription in synapse development and cognitive function. Cold Spring Harb Perspect Biol (2011) 2.27
Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology (2001) 2.18
Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation. N Engl J Med (1978) 2.15
Subunit-specific regulation of NMDA receptor endocytosis. J Neurosci (2004) 2.04
A use-dependent tyrosine dephosphorylation of NMDA receptors is independent of ion flux. Nat Neurosci (2001) 2.02
Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain. J Neurosci (2012) 1.82
Altered Excitatory-Inhibitory Balance in the NMDA-Hypofunction Model of Schizophrenia. Front Mol Neurosci (2008) 1.58
The NMDA receptor antagonist D-2-amino-5-phosphonopentanoate (D-AP5) impairs spatial learning and LTP in vivo at intracerebral concentrations comparable to those that block LTP in vitro. J Neurosci (1992) 1.54
Endocytosis and degradative sorting of NMDA receptors by conserved membrane-proximal signals. J Neurosci (2004) 1.44
NMDA receptor regulation of memory and behavior in humans. Hippocampus (2001) 1.30
Anti-NMDA-Receptor Encephalitis and Other Synaptic Autoimmune Disorders. Curr Treat Options Neurol (2011) 1.22
Emerging links between homeostatic synaptic plasticity and neurological disease. Front Cell Neurosci (2013) 1.03
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol (2008) 21.53
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol (2013) 11.47
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol (2009) 9.25
Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol (2010) 7.97
Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain (2005) 6.81
Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci (2010) 6.44
Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol (2005) 5.89
Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol (2009) 5.75
The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS (2007) 5.18
A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol (2007) 4.63
AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol (2009) 4.49
Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients. J Pediatr (2012) 4.12
Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma. Acta Neuropathol (2009) 3.97
The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis (2012) 3.63
Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis. Ann Neurol (2014) 3.40
Neuronal autoantigens--pathogenesis, associated disorders and antibody testing. Nat Rev Neurol (2012) 3.20
Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist (2007) 3.06
Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol (2011) 2.99
N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol (2012) 2.91
Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology (2012) 2.83
Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: case report. Neurology (2013) 2.82
Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis? Neurology (2011) 2.70
EFA6A-like antibodies in paraneoplastic encephalitis associated with immature ovarian teratoma: a case report. J Neurooncol (2006) 2.67
Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology (2011) 2.57
A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk. Cell (2008) 2.55
Antibodies and neuronal autoimmune disorders of the CNS. J Neurol (2009) 2.40
Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol (2010) 2.36
Astrocytes regulate inhibitory synapse formation via Trk-mediated modulation of postsynaptic GABAA receptors. J Neurosci (2005) 2.32
Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology (2013) 2.32
Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy. Arch Neurol (2009) 2.25
Case records of the Massachusetts General Hospital. Case 34-2011: A 75-year-old man with memory loss and partial seizures. N Engl J Med (2011) 2.21
Frequency and characteristics of isolated psychiatric episodes in anti–N-methyl-d-aspartate receptor encephalitis. JAMA Neurol (2013) 2.12
Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. JAMA Neurol (2013) 2.10
Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol (2014) 2.07
Autoantigen diversity in the opsoclonus-myoclonus syndrome. Ann Neurol (2003) 2.05
How complexity of animal welfare issues can foster differences within the veterinary profession. J Am Vet Med Assoc (2015) 2.02
Cognitive deficits following anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry (2011) 2.01
Anti-NMDA receptor encephalitis causing prolonged nonconvulsive status epilepticus. Neurology (2010) 1.98
Update on anti-N-methyl-D-aspartate receptor encephalitis in children and adolescents. Curr Opin Pediatr (2010) 1.91
Synaptic ribbon enables temporal precision of hair cell afferent synapse by increasing the number of readily releasable vesicles: a modeling study. J Neurophysiol (2008) 1.83
Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain. J Neurosci (2012) 1.82
Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Ann Neurol (2012) 1.80
Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study. J Neurol (2010) 1.72
Autoimmune encephalopathies. Ann N Y Acad Sci (2014) 1.65
Anti-N-methyl-D-aspartate receptor encephalitis during pregnancy. Arch Neurol (2010) 1.59
Paraneoplastic cerebellar degeneration: Yo-expressing tumor revealed after a 5-year follow-up with FDG-PET. J Neurol Sci (2006) 1.57
The emerging link between autoimmune disorders and neuropsychiatric disease. J Neuropsychiatry Clin Neurosci (2011) 1.54
Autoimmune encephalitis in children. J Child Neurol (2012) 1.53
Tumor blush: left ventricular cardiac hemangioma with supply from both the left anterior descending and circumflex arteries. J Invasive Cardiol (2012) 1.50
A novel treatment-responsive encephalitis with frequent opsoclonus and teratoma. Ann Neurol (2013) 1.50
Young girl with psychosis, cognitive failure and seizures. Tidsskr Nor Laegeforen (2012) 1.47
Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia. Am J Psychiatry (2012) 1.46
Paraneoplastic neurological syndromes: diagnosis and treatment. Curr Opin Neurol (2007) 1.41
Evidence that rapid vesicle replenishment of the synaptic ribbon mediates recovery from short-term adaptation at the hair cell afferent synapse. J Assoc Res Otolaryngol (2004) 1.38
Postsynaptic TrkB-mediated signaling modulates excitatory and inhibitory neurotransmitter receptor clustering at hippocampal synapses. J Neurosci (2004) 1.35
Pattern of neuropsychological performance among HIV positive patients in Uganda. BMC Neurol (2007) 1.35
Isolated hemidystonia associated with NMDA receptor antibodies. Mov Disord (2010) 1.34
Prolonged follow-up and CSF antibody titers in a patient with anti-NMDA receptor encephalitis. Neurology (2011) 1.33
In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction. Orphanet J Rare Dis (2010) 1.33
Anti-N-methyl-D-aspartate receptor encephalitis: a newly recognized inflammatory brain disease in children. Arthritis Rheum (2011) 1.32
Paraneoplastic anti-NMDAR encephalitis: long term follow-up reveals persistent serum antibodies. J Neurol (2011) 1.29
Paraneoplastic neurological syndromes. Curr Opin Neurol (2012) 1.29
Neuro-ophthalmologic manifestations of paraneoplastic syndromes. J Neuroophthalmol (2008) 1.29
Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome. Nat Clin Pract Neurol (2007) 1.29
Movement disorders in paraneoplastic and autoimmune disease. Curr Opin Neurol (2011) 1.28
Paraneoplastic syndromes and autoimmune encephalitis: Five new things. Neurol Clin Pract (2012) 1.25
Treatment-responsive subacute limbic encephalitis and NMDA receptor antibodies in a man. Neurology (2008) 1.23
Organelle positioning in muscles requires cooperation between two KASH proteins and microtubules. J Cell Biol (2012) 1.23
Clinical neuropathology practice guide 5-2012: updated guideline for the diagnosis of antineuronal antibodies. Clin Neuropathol (2012) 1.23
Astrocyte secreted proteins selectively increase hippocampal GABAergic axon length, branching, and synaptogenesis. Mol Cell Neurosci (2009) 1.22
Anti-NMDA-Receptor Encephalitis and Other Synaptic Autoimmune Disorders. Curr Treat Options Neurol (2011) 1.22
Cytoplasmic BK(Ca) channel intron-containing mRNAs contribute to the intrinsic excitability of hippocampal neurons. Proc Natl Acad Sci U S A (2008) 1.20
Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology (2014) 1.19
Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease. J Neurol Neurosurg Psychiatry (2012) 1.17
Mass spectrometric and computational analysis of cytokine-induced alterations in the astrocyte secretome. Proteomics (2009) 1.17
Psychiatric manifestations of paraneoplastic disorders. Am J Psychiatry (2010) 1.16
Diagnosis and management of paraneoplastic neurologic disorders. Curr Treat Options Oncol (2013) 1.15
Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies. Eur J Neurosci (2010) 1.13
Cellular plasticity induced by anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis antibodies. Ann Neurol (2015) 1.13
Autoimmune encephalitis as differential diagnosis of infectious encephalitis. Curr Opin Neurol (2014) 1.13
Large releasable pool of synaptic vesicles in chick cochlear hair cells. J Neurophysiol (2004) 1.12
Neuromuscular synaptogenesis in wild-type and mutant zebrafish. Dev Biol (2005) 1.12
Anti-N-methyl-D-aspartate receptor encephalitis: characteristic behavioral and movement disorder. Arch Neurol (2010) 1.11
Timed Gait test: normative data for the assessment of the AIDS dementia complex. J Clin Exp Neuropsychol (2006) 1.09
Neurobeachin is essential for neuromuscular synaptic transmission. J Neurosci (2004) 1.08
Reduced gap junctional coupling leads to uncorrelated motor neuron firing and precocious neuromuscular synapse elimination. Proc Natl Acad Sci U S A (2007) 1.08
Persistent intrathecal antibody synthesis 15 years after recovering from anti-N-methyl-D-aspartate receptor encephalitis. JAMA Neurol (2013) 1.08
In vivo imaging of preferential motor axon outgrowth to and synaptogenesis at prepatterned acetylcholine receptor clusters in embryonic zebrafish skeletal muscle. J Neurosci (2006) 1.07